Effect of astaxanthin intake in patients affected by type 2 diabetes mellitus

Early Phase 1

Conditions: Diabetes.
E11,E12
Non-insulin-dependent diabetes mellitus, Malnutrition-related diabetes mellitus

Registration Number: IRCT2015081623645N1

Lead Sponsor: Vice chancellor for research, Ahvaz Jundishapour University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 48

Inclusion Criteria

Willingness to participate in the study, age range between 30-60 years old, Body Mass Index range between 19 and 35 kg per m2, HbA1C more than seven, not to be affected by renal, liver, lung and autoimmune disease, normal thyroid status, patients who have received standard oral treatments for at least six months.
Exclusion criteria:Failure to follow the study

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FBS. Timepoint: at first and two months after intervention. Method of measurement: glucose enzymatic kit.;Fructosamine. Timepoint: at first and two months after intervention. Method of measurement: ELISA.;HDL. Timepoint: at first and two months after intervention. Method of measurement: spectrophotometer.;LDL. Timepoint: at first and two months after intervention. Method of measurement: spectrophotometer.;TG. Timepoint: at first and two months after intervention. Method of measurement: spectrophotometer.;IL6. Timepoint: at first and two months after intervention. Method of measurement: Elisa kit.;Adiponectin. Timepoint: at first and 2 months after intervention. Method of measurement: ELISA.;MDA. Timepoint: at first and two months after intervention. Method of measurement: TBARS.

Secondary Outcome Measures